綠庭投資(600695.SH)控股股東之一致行動人689萬股解除質押
格隆匯4月14日丨綠庭投資(600695.SH)公佈,公司於2020年4月14日收到控股股東之一致行動人綠庭科創關於辦理部分股份解除質押的通知,綠庭科創將質押給東方證券股份有限公司2227.4萬股股份中的689萬股辦理了解除質押,剩餘未解除質押的1538.4萬股股份的質押式回購之購回交易日為2020年6月11日。
公司控股股東綠庭香港之一致行動人綠庭科創持有公司無限售條件流通A股3689.43萬股,佔公司總股本的比例為5.19%。本次股份解除質押後,綠庭科創累計質押公司股份1538.4萬股,佔其持有公司股份的比例為41.70%,佔公司總股本的比例為2.16%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.